Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Respiratory Distress Syndrome, Newborn

• Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
• An Open-label Study of the Safety and Pharmacokinetics of the TGKP
• the Incidence of Necrotizing Enterocolitis in Preterm With Respiratory Distress Syndrome Undergoing Caffeine Therapy
• Non Inferiority Trial Investigating Surfactants Administered Via MIST
• To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
• Prophylactic Minimally Invasive Surfactant Evaluation
• Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
• Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS
• Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
• Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome
• The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
• Inhaled Sevoflurane for ARDS Prevention
• Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
• Antenatal Dexamethasone for Late Preterm Deliveries
• Vascular ARDS Recruitment After Inhaled Nitric Oxide
• A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
• Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
• Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
• Sedative Effect and Safety of Remimazolam Besylate in ARDS Patients
• Implementing LISA Surfactant in Nigeria
• Sivelestat for Acute Respiratory Distress Syndrome Due to COVID-19
• Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
• Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
• Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Moderate or Severe COVID-19
• 5-HT3 Receptor Antagonist and Respiratory Drive in Patients With ARDS
• Add-on Reparixin in Adult Patients With ARDS
• Study to Verify the Effectiveness and Safety of the Modified Isothymol or Carvacrol Compound Against SARS-CoV-2
• Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
• Glucocorticoid Therapy for Acute Respiratory Distress Syndrome
• Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
• Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial
• Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium
• Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
• Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS
• Nebulised BromAc in Healthy Volunteers
• Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19
• A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms
• Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS
• AVICOVID-3 Inhaled Use of Zyesami for Treatment of Severe COVID-19
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Acute Respiratory Distress Syndrome: A Phase I/II Clinical Trial
• AV-001 for Hospitalized Patients With COVID-19 Disease
• Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy
• Pirfenidone to Prevent Fibrosis in Ards.
• Premedication for Less Invasive Surfactant Administration Study (PRELISA)
• A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19
• Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection
• A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome
• Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
• Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
• Nigelle 5CH in Prevention of Influanza
• Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
• Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial
• Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
• Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19
• Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
• Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
• A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.
• In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection
• A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
• Treatment of ARDS With Sivelestat Sodium
• Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
• Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
• Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
• Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress Syndrome
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
• Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
• Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
• Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19
• A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
• Roflumilast in ARDS
• Tolerability and Efficacy of RJX in Patients With COVID-19
• Fenofibrate for Patients With COVID-19 Requiring Hospitalization
• Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19
• A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia
• SILtuximab in Viral ARds (SILVAR) Study
• Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build
• Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
• The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
• An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.
• Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
• The Budesonide in Babies (BiB) Trial
• Trial of Therapeutic Hypothermia in Patients With ARDS
• A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
• Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
• Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
• A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
• Telmisartan in Respiratory Failure Due to COVID-19
• Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)
• Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
• Efficacy and Safety of Itolizumab in COVID-19 Complications
• Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
• VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
• Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
• Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
• This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Diffi
• Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
• The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)
• Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress Syndrome
• Lessening Organ Dysfunction With VITamin C in Septic ARDS
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
• Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
• A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
• Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial
• Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
• Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19
• The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
• COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
• Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19
• Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome
• A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes
• CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
• MSCs in COVID-19 ARDS
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
• Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19
• Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
• Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19
• Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)
• A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
• Polyvalent Immunoglobulin in COVID-19 Related ARds
• BAttLe Against COVID-19 Using MesenchYmal Stromal Cells
• Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19
• Spironolactone in Covid-19 Induced ARDS
• Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
• LIBERATE Trial in COVID-19
• Pre-exposure Prophylaxis for SARS-Coronavirus-2
• Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
• COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
• The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
• Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19
• The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
• Surfactant Nebulization for the Early Aeration of the Preterm Lung
• Losartan for Patients With COVID-19 Requiring Hospitalization
• Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
• Losartan for Patients With COVID-19 Not Requiring Hospitalization
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
• Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
• Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.
• Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome
• SEvoflurane for Sedation in ARds
• Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients
• Medium vs Low Oxygen Threshold for the Surfactant Administration
• Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.
• Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
• Caffeine Treatment in in the Delivery Room
• Sevoflurane PharmacokInetics in ARDS
• Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
• Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation.
• Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course
• Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome
• A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact
• The Role of ARTificial Uterine CONtractions in Perinatal Respiratory Morbidity of Term Infants Delivered by Elective Caesarean Section
• Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope
• 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
• Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
• Premedication for Less Invasive Surfactant Administration
• Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants
• Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome
• Long Term Outcome on Brain and Lung of Different Oxygen Strategies in ARDS Patients
• Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
• Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
• Effect of Antenatal Corticosteroids on Neonatal Morbidity.
• Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS
• Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome
• Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
• N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
• Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
• The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium
• Intratracheal Budesonide/Surfactant Prevents BPD
• Vaginal Misoprostol to Improve the Neonatal Respiratory Outcome
• A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
• Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
• Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)
• Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS
• Iloprost in Acute Respiratory Distress Syndrome
• Vitamin D to Improve Outcomes by Leveraging Early Treatment
• Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
• Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
• A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome
• Effect of Antenatal Steroid on Pulmonary Artery Blood Flow
• Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients
• Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?
• PGE1 as Additive Anticoagulant in ECMO-Therapy
• The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)
• Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome
• Does The Surfactant Administration by Aerosolization Effective?
• Corticosteroid Mediates Acute Respiratory Distress Syndrome
• Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
• A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration
• Liberal Oxygenation Versus Conservative Oxygenation in ARDS
• The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
• Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)
• Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia
• Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
• Reevaluation Of Systemic Early Neuromuscular Blockade
• Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS
• Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
• A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)
• Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
• Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
• ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial
• A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants
• Aerosolized Surfactant in Neonatal RDS
• Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
• Trial of an Alternate Mode of Providing Artificial Breaths to Children With Very Severe Pneumonia
• Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)
• Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome
• Safety and Efficacy Study of Acthar in Subjects With ARDS
• Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
• Supported Ventilation in ARDS Patients
• Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
• Curosurf/Budesonide for Infants With Respiratory Distress Syndrome
• Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
• Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations
• Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide
• Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome
• Perfusion Index Variability in Respiratory Distress Syndrome
• LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
• Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
• Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children
• Premedication for Non-Emergency Endotracheal Intubation In the NICU
• Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome
• Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS
• Hyperoxia and Hypertonic Saline in Septic Shock
• A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants
• Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury
• First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
• Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma
• Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
• Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)
• Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome
• Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room
• LIPS-A: Lung Injury Prevention Study With Aspirin
• Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
• Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
• Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
• Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome
• Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome
• Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
• Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
• Iloprost Effects on Gas Exchange and Pulmonary Mechanics
• Trial of Steroids in Pediatric Acute Lung Injury/ARDS
• Intratracheal Vitamin A Administration With Surfactant for Newborn Respiratory Distress Syndrome
• Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
• Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
• Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants
• Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
• Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
• Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS)
• The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)
• Sleep Intervention During Acute Lung Injury
• Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
• SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
• Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
• STIP: Statin Trial for Influenza Patients
• Prevention of Chronic Lung Disease (CLD) in Preterm Infants
• Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
• Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS)
• Genetic Regulation of Surfactant Deficiency
• Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
• Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)
• Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
• Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
• Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)
• Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
• Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks
• Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy
• Calfactant for Direct Acute Respiratory Distress Syndrome
• Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study
• Early Insulin and Development of ARDS
• Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
• Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
• Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study
• Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
• Drug Study of Albuterol to Treat Acute Lung Injury
• Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
• Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"
• Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome
• A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
• Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
• Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth
• Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
• Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome
• Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams
• Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome
• Nitric Oxide Administration for Acute Respiratory Distress Syndrome
• IC14 Antibodies to Treat Individuals With Acute Lung Injury
• Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost
• KL₄Surfactant Treatment in Patients With ARDS
• SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
• Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
• A Randomized Trial of GM-CSF in Patients With ALI/ARDS
• Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation
• Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
• Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants
• Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
• Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section
• Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
• Activated Protein C to Treat Acute Lung Injuries
• Carbon Monoxide to Prevent Lung Inflammation
• A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
• Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
• Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
• Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
• Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants
• Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
• Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery
• Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
• Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
• Ibuprofen in Sepsis Study
• Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
• Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration